Inauguration of the brand new premises of Novaptech, a leading biotechnology company producing aptamers for the detection of contaminants in the food industry
Novaptech, an innovative biotechnology company, inaugurated its new premises in Gradignan on May 31st, 2024, in the presence of Mr Alain Rousset, President of the Conseil Régional de Nouvelle-Aquitaine. Created in 2016 from Jean-Jacques Toulmé’s academic laboratory at the University of Bordeaux, Novaptech currently has 9 employees and plans to recruit a further 5 by the end of 2025.
Specialising in the development of aptamers, Novaptech stands out as the only French company to master this breakthrough technology. Aptamers, which can replace antibodies in all analytical, diagnostic and therapeutic applications, are at the heart of Novaptech’s strategy. The company is initially focusing on the development of biosensors for real-time detection of contaminants in the agri-food industry, such as pesticides, micropollutants and endocrine disruptors, in response to the need for rapid, simple and decentralised testing.
In line with the objectives of the Neo Terra strategic roadmap drawn up by the Conseil Régional de Nouvelle-Aquitaine for the ecological and energy transition, Novaptech recently validated its first laboratory-scale aptasensor.
The Conseil Régional de Nouvelle-Aquitaine has supported Novaptech since its creation. Once again this year, the Region has supported the company in strengthening its export strategy, particularly in Asia.
The inauguration of these brand new premises marks an important step for Novaptech, consolidating its role as a leader in the biotechnology sector and its commitment to innovation and the protection of public health.
For more details, read the full press release from the Cabinet of President Alain Rousset here (in French).
EN 
FR